Issue - meetings

(i)            to note the benefits of the continued collaboration between the Marywell Practice and the Integrated Drug Service;

(ii)          to note the Options Appraisal (at Appendix A of the report) and multi-agency and service user consultations (at Appendix E);

(iii)         to agree to implement Option 2, namely for Marywell General Practice to continue to operate as a 2c General Medical Service (Specialist Service); and

(iv)         to agree that the recurring alignment of Alcohol & Drugs Partnership (ADP) funding of £100,000 to Marywell Practice should proceed to implement Option 2 referred to at (iii) above.

The Board had before it an update prepared by the Primary Care Development Manager on the Marywell Practice redesign, its consideration of options and recommendations on the service’s future direction.

The report recommended:-

that the Board:

(a)          note the benefits of the continued collaboration between the Marywell Practice and the Integrated Drug Service;

(b)          note the Options Appraisal (at Appendix A of the report) and multi-agency and service user consultations (at Appendix E);

(c)          agree to implement Option 2, namely for Marywell General Practice to continue to operate as a 2c General Medical Service (Specialist Service); and

(d)          agree that the recurring alignment of Alcohol & Drugs Partnership (ADP) funding of £100,000 to Marywell Practice should proceed to implement Option 2 referred to at (c) above.

The Board resolved:-

to agree the recommendations.